Search
for
Sort by
Research 781–810 of 1000+
- Highlights
- Polycystic ovary syndrome
- Polycystic ovary syndrome in adults : a literature review and clinical practice guideline for the primary care nurse practitioner
- New Insights Into the Relationship Between the Skin and Endocrine Disorders
- Early Onset Werner Syndrome
- Metabolic Aspects of Polycystic Ovary Syndrome
- Inositol versus metformin administration in polycystic ovarian disease patients
- Frontal fibrosing alopecia: Iatrogenic endocrine disruption
- Workup and Management of Polycystic Ovary Syndrome
- Comparison of androgenic alopecia distribution among type 2 diabetes and healthy women in Isfahan city: a brief report
- Polycystic ovarian disease in adult and perimenopausal women
- Mucocutaneous Manifestations of Endocrine Disorders
- The influence of non-esterified fatty acids (NEFA) on the ovarian production of androgens in a context of in vitro fertilisation (IVF) – preliminary results
- Definition criteria and diagnostic assessments
- Appropriate use of metformin in early pregnancy: is there a role for first trimester use?
- Screening for Abnormal Glucose Metabolism in Adolescents with Polycystic Ovary Syndrome (PCOS)
- Approaches to lifestyle management in polycystic ovary syndrome
- Effects of polycystic ovary syndrome on female reproduction
- Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials
- Management of pregnancy in a carrier of the Donohue mutation
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks
- First case of V281+I172N/V281L CYP21A2 genotype associated with congenital adrenal hyperplasia form. A case report from South Italy
- Actualités du SOPK
- Del "contexto expandido" a la mesa de negociación
- In the quest to stymie time, will laboratory data stand up in man?
- Botulinum toxin: Pearls & pitfalls
- Update on nail disorders
- Metabolic syndrome
- NEW PROPRIETARY BRANDS: Gabapentin